Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 39 peer-reviewed journal articles Updated
Neurology

Understanding Kennedy Disease (SBMA)

At a Glance

Kennedy Disease, also known as Spinal and Bulbar Muscular Atrophy (SBMA), is a rare, inherited neuromuscular disorder primarily affecting males. Unlike ALS, it progresses very slowly over decades. Most patients maintain a near-normal life expectancy while adapting to gradual changes in muscle strength.

Receiving a diagnosis of Kennedy Disease, also known as Spinal and Bulbar Muscular Atrophy (SBMA), can feel overwhelming. It is natural to feel anxious when hearing terms like “muscular atrophy” or “motor neuron disease.” However, it is important to know that while Kennedy Disease is a life-altering condition, it is significantly different from more rapid, aggressive neuromuscular disorders you may have heard of, such as ALS (Amyotrophic Lateral Sclerosis) [1][2].

Kennedy Disease is a rare, inherited disorder that primarily affects males [3]. It is characterized by its very slow progression; most individuals with this condition maintain a near-normal life expectancy and can continue to live active, fulfilling lives for many decades after symptoms first appear [2][1].

What is Kennedy Disease (SBMA)?

Kennedy Disease is a neuromuscular disorder, meaning it affects both the nerves and the muscles. Specifically, it involves the lower motor neurons, which are the nerve cells in the spinal cord and brainstem that tell your muscles to move [4].

The disease is caused by a genetic change in the androgen receptor (AR) gene [5]. Inside this gene, a specific segment of DNA (called a CAG repeat) becomes longer than it should be [6]. This genetic “stutter” causes the body to produce a protein that doesn’t fold correctly. Over time, this toxic protein builds up in the motor neurons and muscle cells, preventing them from working properly [4][7].

Why “Spinal and Bulbar”?

The name Spinal and Bulbar Muscular Atrophy describes the two main areas where the disease is most active:

  • Spinal: Refers to the nerves in the spinal cord that control the muscles in your arms and legs [3].
  • Bulbar: Refers to the “bulb-shaped” part of the brainstem that controls the muscles used for speaking, swallowing, and chewing [3][1].

Understanding the Progression

The most important thing to understand about Kennedy Disease is its pace. Symptoms typically begin in middle age (usually between 30 and 50) and progress very gradually over many years [3][1].

Feature Kennedy Disease (SBMA) ALS (Amyotrophic Lateral Sclerosis)
Speed of Change Very slow (decades) [2] Rapid (months to years) [1]
Life Expectancy Near-normal [1] Typically 2–5 years after diagnosis
Sensory Symptoms Common (numbness/tingling) [8] Rare
Other Features Hormonal/Metabolic changes [9] Primarily motor-focused

Because the progression is so slow, many patients find that they can adapt to physical changes as they occur. While you may eventually need walking aids or experience changes in your voice, these transitions often happen over the course of decades, not months [1][10].

Navigating This Guide

To help you better understand and manage your condition, we have broken down the information into the following sections. Please explore the topics below:

01

Symptoms and Multisystem Impact of Kennedy Disease

Learn about the multisystem symptoms of Kennedy Disease. Understand how it affects motor and sensory nerves, hormones, and metabolism over time.

02

Genetics and Diagnosis: Finding the Answer

Learn about Kennedy Disease genetics and diagnosis. Understand the AR gene, CAG repeats, inheritance, and how testing distinguishes this condition from ALS.

03

Managing Your Health: Treatment and Care

Explore Kennedy disease treatment options and management strategies. Learn why testosterone is dangerous, how to manage swallowing, and metabolic monitoring.

04

Building Your Care Team

Learn how to build a multidisciplinary care team for Kennedy Disease (SBMA). Discover the essential specialists you need and how to prepare for appointments.

05

Long-Term Monitoring and Living Well

Learn how to proactively manage Kennedy Disease (SBMA). Discover essential long-term monitoring strategies for swallowing, lung function, and metabolic health.

Common questions in this guide

What is the difference between Kennedy Disease and ALS?
While both are neuromuscular disorders, Kennedy Disease progresses very slowly over decades, and most patients have a near-normal life expectancy. In contrast, ALS is much more rapid and aggressive, typically progressing over months to a few years.
What causes Kennedy Disease (SBMA)?
Kennedy Disease is caused by a genetic mutation in the androgen receptor gene. A specific segment of DNA, known as a CAG repeat, becomes too long. This causes the buildup of a toxic protein that damages motor neurons over time.
Why is it called Spinal and Bulbar Muscular Atrophy?
The name describes the two main nerve areas affected by the disease. 'Spinal' refers to the nerves controlling the muscles in your arms and legs, while 'bulbar' refers to the brainstem area that controls the muscles used for speaking, swallowing, and chewing.
Should I avoid testosterone treatments if I have Kennedy Disease?
Because Kennedy Disease involves a mutation in the androgen receptor gene, certain hormone treatments like testosterone may need to be avoided. You should discuss all medications and supplements with your neurologist to ensure they are safe for your specific condition.
Will Kennedy Disease shorten my life expectancy?
Most individuals with Kennedy Disease maintain a near-normal life expectancy. Because the disease progresses very gradually, many patients are able to adapt to physical changes as they occur over several decades.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the specific number of CAG repeats found in my genetic test, and how does that typically relate to my symptoms?
  2. 2.Based on my current symptoms, how would you describe my rate of progression compared to others with Kennedy Disease?
  3. 3.How often should I have my swallowing and respiratory function evaluated to ensure I stay ahead of any changes?
  4. 4.Should I be screened for metabolic issues like insulin resistance or high cholesterol as part of my regular care?
  5. 5.Are there any medications or hormone treatments (like testosterone) that I should avoid because of this diagnosis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Kennedy's disease: an under-recognized motor neuron disorder.

    Malek EG, Salameh JS, Makki A

    Acta neurologica Belgica 2020; (120(6)):1289-1295 doi:10.1007/s13760-020-01472-6.

    PMID: 32839928
  2. 2

    Spinal and Bulbar Muscular Atrophy.

    Grunseich C, Fischbeck KH

    Neurologic clinics 2015; (33(4)):847-54.

    PMID: 26515625
  3. 3

    Clinical manifestations and AR gene mutations in Kennedy's disease.

    Liu X, Zhu M, Li X, Tang J

    Functional & integrative genomics 2019; (19(3)):533-539 doi:10.1007/s10142-018-0651-7.

    PMID: 30612224
  4. 4

    Spinal and Bulbar Muscular Atrophy Overview.

    Fischbeck KH

    Journal of molecular neuroscience : MN 2016; (58(3)):317-20 doi:10.1007/s12031-015-0674-7.

    PMID: 26547319
  5. 5

    Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.

    Kim H, Lim YM, Lee EJ, et al.

    Muscle & nerve 2018; (57(4)):683-686 doi:10.1002/mus.25977.

    PMID: 28972672
  6. 6

    Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.

    Grunseich C, Fischbeck KH

    Current opinion in neurology 2020; (33(5)):629-634 doi:10.1097/WCO.0000000000000856.

    PMID: 32773451
  7. 7

    A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases.

    Cristofani R, Crippa V, Cicardi ME, et al.

    Frontiers in aging neuroscience 2020; (12()):191 doi:10.3389/fnagi.2020.00191.

    PMID: 32792938
  8. 8

    Nerve ultrasound detects abnormally small nerves in patients with spinal and bulbar muscular atrophy.

    Pelosi L, Ghosh A, Leadbetter R, et al.

    Muscle & nerve 2022; (65(5)):599-602 doi:10.1002/mus.27509.

    PMID: 35092036
  9. 9

    Metabolic alterations in spinal and bulbar muscular atrophy.

    Francini-Pesenti F, Vitturi N, Tresso S, Sorarù G

    Revue neurologique 2020; (176(10)):780-787 doi:10.1016/j.neurol.2020.03.020.

    PMID: 32631678
  10. 10

    Exercise Intervention Leads to Functional Improvement in a Patient with Spinal and Bulbar Muscular Atrophy.

    Compo J, Joseph J, Shieh V, et al.

    Journal of rehabilitation medicine. Clinical communications 2020; (3()):1000041 doi:10.2340/20030711-1000041.

    PMID: 33884143

This page provides educational information about Kennedy Disease (SBMA) and its progression. It is not a substitute for professional medical advice or diagnosis from your neurologist or healthcare team.

Get notified when new evidence is published on Kennedy disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.